W e

Laboratory Members



Discover Walk for the Beckman Center



A goal of our laboratory is to develop methods to rapidly and reversibly regulate mammalian genes that could be used like temperature-sensitive alleles in model organisms. We believe that understanding complex biologic processes will require rapid activation and inaction of proteins to allow one to remove or add the function of a protein in a living organism and then follow the orderly sequence of biochemical changes that follow. This approach allows one to define steps in biochemical pathways and distinguish causality from coincidence. As our approach we chose to use small, membrane-permeable molecules to regulate proximity of proteins, because proximity is one of the most widely used biologic control mechanisms. As seen in the illustration below we conceived of small molecules that readily pass into cells and then bring proteins into proximity by virtue of binding to small protein tags on the protein of interest (Spencer et al. Science 1993). We call these molecules CIDs or Chemical Inducers of Dimerization. A variety of CIDs of different chemical classes have been made and used to regulate nearly all levels of signaling and processes as diverse as secretion, transcription and chromosome separation. Our studies began several years ago with Stuart Schreiber in the Department of Chemical Biology at Harvard. This approach has been used at Ariad Pharmaceuticals in Cambridge to develop methods for human gene therapy and they maintain a web site for distributing materials.

Recently, Kryn Stankunas, Hank Bayle and Jason Gastwicki in the lab have developed a method to regulate the stability of proteins that appears to be applicable to many genes. They have used homologous recombination to insert a small peptide tag that destabilizes the parent protein giving the null phenotype in mice. Addition of rapamycin or a non-toxic analogue, C20-methallyl rapamycin leads to rapid stabilization of the protein and restoration of function. We have recently used this to demonstrate that GSK3b executes its functions at two different times during development and to dissect the mechanisms underlying cleft palate.


Some papers on the development and use of induced proximity for controlling biologic processes

Spencer et al Science 1993 The frist use of synthetic ligands to control signaling.

Spencer et al PNAS 1995 The first use of synthetic ligands to control non-receptor tyrosine kinases

Biggar SR, Crabtree GR. EMBO 2001 The use of induced proximity to direct either binary or graded (analogue) transcriptional activation in yeast.

Holsinger et al PNAS The first use of synthetic ligands to control exchange factors

Ho et al Nature. 1996 Aug 29;382(6594):822-6 The use of CID's to dissect mechanisms of transcription.

Spencer et al Current Biology 1996 and Belshaw et al Chem Biol 1996 The use of synthetic ligands to control death receptors

Ye X et al Science. 1999 Jan 1;283(5398):88-91 The use of CIDs for regulated gene therapy

Rivera et al Science 1999 1;283(5398):88-91 The use of CID's to control secretion of therapeutic proteins

Gruber S,..., Nasmyth K. Cell. 2006 Nov 3;127(3):523-37. The use of induced proximity to control chromosome separation in yeast











  Design and Content by G R Crabtree